CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 40 target
Drug / intervention
Volume-stable collagen matrix Geistlich Fibro-Gide®device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05081284
NCT05081284N/AActiveUpdate OverdueCompletion was 18mo ago
Enrollment Stalled
CompareCT.gov

Clinical Outcomes of Immediate Implants With or Without a Volume-stable Collagen Matrix: a Randomized Controlled Clinical Trial

University of Pisa·interventional·Posted Oct 18, 2021·Updated May 6, 2026

In Brief

A clinical study evaluating Volume-stable collagen matrix Geistlich Fibro-Gide® for Edentulous Alveolar Ridge. Active but no longer recruiting, targeting 40 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

The purpose of this study is to evaluate the soft tissue clinical results in patients that received, or not, a soft tissue augmentation around dental implant inserted immediately after the extraction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEdentulous Alveolar Ridge
CountriesItaly
Collaborators--

Timeline

N/AActive
2022202320242025202620272028
First PostedOct 18, 2021
Enrollment StartJan 10, 2022
Primary CompletionDec 31, 2024
Study CompletionDec 31, 2027
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 4.7 years ago

Interventions

Volume-stable collagen matrix Geistlich Fibro-Gide®device

After tooth extraction and implant insertion the Test group will receive a soft tissue augmentation on the buccal side oh the implant. an envelop flap will be raised and a volume-stable collagen graft will be stabilized with sutures. Control group will not receive soft tissue augmentation.